It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Human T-lymphotropic viruses 1 and 2 (HTLV-1/2) have a worldwide distribution. HTLV-1 has been associated with several diseases, including an aggressive malignant disease known as adult T-cell leukemia/lymphoma and a chronic inflammatory neurological disease called HTLV-1-associated myelopathy, while HTLV-2 has not been definitively associated with diseases. HTLV-2 is most prevalent in specific groups such as injecting drug users and the indigenous population. In Brazil, most studies about HTLV in indigenous are carried out in indigenous communities from the north of the country. Mato Grosso do Sul (MS), Central Brazil, has the second-largest indigenous population in Brazil. However, there is no available data about HTLV infection in this group. We conducted the first investigation of HTLV-1/2 infection prevalence in the indigenous population from Jaguapiru and Bororó villages in Dourados City, MS, to provide the prevalence and molecular characterization of HTLV. For that, a total of 1875 indigenous participated in the study. All the serum samples were screened by an enzyme-linked immunosorbent assay commercial kit for the presence of anti-HTLV-1/2 antibodies. Positive samples were confirmed by HTLV-1/2 Western Blot assay. The HTLV-1 5’LTR region was detected by nested PCR amplification and sequenced by Sanger. Most of the study population declared belonging to Guarani-Kaiowá ethnicity (69.18%), 872 (46.51%), and 1003 (53.49%) were from Jaguapiru and Bororó villages, respectively. The median age of participants was 31 years, and 74.24% were females. Two individuals were detected with HTLV-1 (0.1%; CI 95% 0.1–0.2). The phylogenetic analysis revealed that isolates belong to the Cosmopolitan subtype and the Transcontinental subgroup (HTLV-1aA). The low HTLV-1 prevalence found in this study is similar to that observed among blood donors, and pregnant populations from Mato Grosso do Sul. The absence of HTLV-2 infection among these Brazilian indigenous communities would suggest a distinct behavior pattern from other indigenous populations in Brazil.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Universidade Federal de Mato Grosso do Sul, Campo Grande, Brazil (GRID:grid.412352.3) (ISNI:0000 0001 2163 5978)
2 Universidade de São Paulo, Faculdade de Medicina, São Paulo, Brazil (GRID:grid.11899.38) (ISNI:0000 0004 1937 0722)
3 Universidade Federal de Mato Grosso do Sul, Campo Grande, Brazil (GRID:grid.412352.3) (ISNI:0000 0001 2163 5978); Secretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande, Brazil (GRID:grid.412352.3)
4 Universidade Federal da Grande Dourados, Dourados, Brazil (GRID:grid.412335.2) (ISNI:0000 0004 0388 2432)
5 Instituto Evandro Chagas, Ananindeua, Brazil (GRID:grid.419134.a) (ISNI:0000 0004 0620 4442)
6 Universidade Federal do Pará, Belém, Brazil (GRID:grid.271300.7) (ISNI:0000 0001 2171 5249)
7 Universidade Federal de Mato Grosso do Sul, Campo Grande, Brazil (GRID:grid.412352.3) (ISNI:0000 0001 2163 5978); Fundação Oswaldo Cruz/Ministério da Saúde/Brasil, Fiocruz Mato Grosso do Sul, Campo Grande, Brazil (GRID:grid.412352.3)